CTHRC1 and postmenopausal osteoporosis: It is noteworthy in this article that Cthrc1 may have a potential role in treating osteoporosis, because we observed that osteoblast-specific overexpression of Cthrc1 in mice attenuates bone loss which is induced by OVX, an accepted preclinical disease model of postmenopausal osteoporosis.